Christine Roth

Christine Roth is an accomplished leader in the oncology field with extensive experience in product strategy and commercialization. Currently serving as the Head of Global Product Strategy and Commercialization at Bayer since March 2022, Christine also holds the title of Executive Vice President, Head of the Oncology Strategic Business Unit. Prior to this role, Christine was at GSK as Senior Vice President, Global Oncology Therapy Area Head from December 2017 to March 2022, and at Novartis as Vice President, Breast Cancer Franchise Head and Global Disease Leader in Hematology from March 2015 to December 2017. Christine's earlier roles include Vice President at GlaxoSmithKline, leading medicine commercialization for the Global Oncology Franchise, and Executive Director at Bristol-Myers Squibb, overseeing marketing and commercialization for key oncology therapies like Erbitux and Ipilimumab (Yervoy).